Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TtgR is a key transcriptional repressor in Pseudomonas putida that belongs to the TetR family of regulators. It plays a critical role in bacterial survival by controlling the expression of the TtgABC multidrug efflux pump, which expels a diverse array of toxic substances including antibiotics, organic solvents, and plant secondary metabolites (UniProt P0C0V2). TtgR binds as a homodimer to the operator DNA, sterically hindering RNA polymerase and preventing transcription of the efflux system (Alguel et al., 2007). Upon binding to various ligands such as chloramphenicol or flavonoids, TtgR undergoes a conformational change that triggers its dissociation from the DNA, thereby inducing the expression of the efflux system (Teran et al., 2003). This regulatory mechanism allows the bacteria to rapidly adapt to the presence of environmental toxins and antimicrobial agents. Because it regulates a broad-spectrum resistance mechanism, TtgR is a significant target for research into antimicrobial resistance and the development of efflux pump inhibitors to restore antibiotic efficacy. Inhibiting TtgR or preventing its dissociation could potentially sensitize resistant strains to existing antimicrobial treatments.
Ligand-induced conformational change leading to dissociation from the DNA operator and subsequent de-repression of efflux pump transcription
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TtgABC operon repressor (TtgR) (TtgR).